Not logged in.png)
Share.png)
SaveReal-World Outcomes of Adjuvant Therapy in Stage III Melanoma and the Impact of Somatic Mutations
Effiom, Derek; Aprati, Tyler; Karneris, Anastasios; Lawless, Aleigha; Sharova, Tatyana; Johnson, Rebecca; Menzies, Alexander; Long, Georgina; Park, Benjamin; Jung, Seungyeon; Johnson, Douglas; Liu, David; Bai, Xue; Flaherty, Keith; Sullivan, Ryan; Boland, Genevieve M.; Cohen, Sonia Share Save Clinicopathological Features and Prognoses of Patients With Splenic Metastases From Breast Cancer: A Single-Centre, Retrospective StudyXie, Xiaofeng; Ma, Mingrui; Bai, Xue; Hu, Jing; Zheng, Haijie; Guo, Xiongqi; Huang, Jiayi; Chen, Xuelian; Chen, Liping; Lan, Xiaofeng; Song, Lin; Du, Caiwen Share Save Share Save Share Save Share Save Share Save Dynamic Change of PD-L2 on Circulating Plasma Extracellular Vesicles as a Predictor of Treatment Response in Melanoma Patients Receiving Anti-PD-1 TherapySun, Linzi; Wei, Xiaoting; Zhao, Qian; Mao, Lili; Bai, Xue; Li, Caili; Gu, Junjie; Kong, Yan; Cui, Chuanliang; Chi, Zhihong; Sheng, Xinan; Lian, Bin; Wang, Xuan; Li, Siming; Yan, Xieqiao; Tang, Bixia; Zhou, Li; Li, Juan; Guo, Jun; Si, Lu; Dai, Jie Share Save The updated report of phase I trial of VG2025, a non-attenuated HSV-1 oncolytic virus expressing IL-12 and IL-15/Ra payloads, in patients with advanced solid tumorsShen, Y.; Rahimian, S.; Qin, A.; Qiu, Y.; Fang, T.; Liang, X.; Li, Y.; Tan, Q.; Zhao, R.; Bai, X.; Liang, T. Share Save Share Save Dabrafenib plus trametinib versus anti-PD-1 monotherapy as adjuvant therapy in BRAF V600-mutant stage III melanoma after de fi nitive surgery: a multicenter, retrospective cohort study (vol 65, 102290, 2023)Bai, Xue; Shaheen, Ahmed; Grieco, Charlotte; Arienzo, Paolo D.; Mina, Florentia; Czapla, Juliane A.; Lawless, Aleigha R.; Bongiovanni, Eleonora; Santaniello, Umberto; Zappi, Helena; Dulak, Dominika; Williamson, Andrew; Lee, Rebecca; Gupta, Avinash; Li, Caili; Si, Lu; Ubaldi, Martina; Yamazaki, Naoya; Ogata, Dai; Johnson, Rebecca; Park, Benjamin C.; Jung, Seungyeon; Madonna, Gabriele; Hochherz, Juliane; Umeda, Yoshiyasu; Nakamura, Yasuhiro; Gebhardt, Christoffer; Festino, Lucia; Capone, Mariaelena; Ascierto, Paolo Antonio; Johnson, Douglas B.; Lo, Serigne N.; V. Long, Georgina; Menzies, Alexander M.; Namikawa, Kenjiro; Mandala, Mario; Guo, Jun; Lorigan, Paul; Najjar, Yana G.; Haydon, Andrew; Quaglino, Pietro; Boland, Genevieve M.; Sullivan, Ryan J.; Furness, Andrew J. S.; Plummer, Ruth; Flaherty, Keith T. Share Save Dabrafenib plus trametinib versus anti-PD-1 monotherapy as adjuvant therapy in BRAF V600-mutant stage III melanoma after definitive surgery: a multicenter, retrospective cohort studyBai, Xue; Shaheen, Ahmed; Grieco, Charlotte; d'Arienzo, Paolo D.; Mina, Florentia; Czapla, Juliane A.; Lawless, Aleigha R.; Bongiovanni, Eleonora; Santaniello, Umberto; Zappi, Helena; Dulak, Dominika; Williamson, Andrew; Lee, Rebecca; Gupta, Avinash; Li, Caili; Si, Lu; Ubaldi, Martina; Yamazaki, Naoya; Ogata, Dai; Johnson, Rebecca; Park, Benjamin C.; Jung, Seungyeon; Madonna, Gabriele; Hochherz, Juliane; Umeda, Yoshiyasu; Nakamura, Yasuhiro; Gebhardt, Christoffer; Festino, Lucia; Capone, Mariaelena; Ascierto, Paolo Antonio; Johnson, Douglas B.; Lo, Serigne N.; Long, Georgina L.; Menzies, Alexander M.; Namikawa, Kenjiro; Mandala, Mario; Guo, Jun; Lorigan, Paul; Najjar, Yana G.; Haydon, Andrew; Quaglino, Pietro; Boland, Genevieve M.; Sullivan, Ryan J.; Furness, Andrew J. S.; Plummer, Ruth; Flaherty, Keith T. Share Save The updated report of phase I trial of VG2025, a non-attenuated HSV-1 oncolytic virus expressing IL-12 and IL-15/RA payloads, in patients with advanced solid tumorsShen, Y.; Rahimian, S.; Qin, A.; Qiu, Y.; Fang, T.; Liang, X.; Li, Y.; Tan, Q.; Zhao, R.; Bai, X.; Liang, T. Share Save Single cell spatial features of in-transit melanoma associated with patient outcome to immunotherapyBai, X.; Quek, C.; Al-Eryani, G.; Harvey, K.; Silva, I.; Menzies, A. M.; Swarbrick, A.; Long, G. V.; Scolyer, R.; Wilmott, J. Share Save Phase Ib study of anlotinib in combination with anti-PD-L1 antibody (TQB2450) in patients with advanced acral melanomaDu, Yu; Dai, Jie; Mao, Lili; Wei, Xiaoting; Bai, Xue; Chen, Ling; Lin, Jing; Chi, Zhihong; Cui, Chuanliang; Sheng, Xinan; Lian, Bin; Tang, Bixia; Wang, Xuan; Yan, Xieqiao; Li, Siming; Zhou, Li; Guo, Jun; Chen, Yu; Si, Lu Share Save Share Save A single-arm phase II clinical trial of anlotinib combined with chemotherapy for the treatment of metastatic triple-negative breast cancerHuang, Jia-Yi; Xie, Xiao-Feng; Chen, Xue-Lian; Zhang, Qiu-Yi; Chen, Li-Ping; Bai, Xue; Lan, Xiao-Feng; Song, Lin; Guo, Jin-Feng; Du, Cai-Wen Share Save Apatinib combined with camrelizumab in advanced acral melanoma patients: An open-label, single-arm phase 2 trialWang, Xuan; Wu, Xiaowen; Yang, Yue; Xu, Weiran; Tian, Hui; Lian, Bin; Chi, Zhihong; Si, Lu; Sheng, Xinan; Kong, Yan; Zhou, Li; Mao, Lili; Li, Siming; Tang, Bixia; Yan, Xieqiao; Bai, Xue; Guo, Jun; Cui, ChuanLiang Share Save Molecular underpinnings of exceptional response in primary malignant melanoma of the esophagus to anti-PD-1 monotherapyDai, Jie; Bai, Xue; Gao, Xuan; Tang, Lirui; Chen, Yu; Sun, Linzi; Wei, Xiaoting; Li, Caili; Qi, Zhonghui; Kong, Yan; Cui, Chuanliang; Chi, Zhihong; Sheng, Xinan; Xu, Zelong; Lian, Bin; Li, Siming; Yan, Xieqiao; Tang, Bixia; Zhou, Li; Wang, Xuan; Xia, Xuefeng; Guo, Jun; Mao, Lili; Si, Lu Share Save PARP Inhibition Induces Synthetic Lethality and Adaptive Immunity in LKB1-Mutant Lung CancerLong, Li -Li; Ma, Si-Cong; Guo, Ze-Qin; Zhang, Yan-Pei; Fan, Zhenzhen; Liu, Li -Juan; Liu, Li; Han, Duan-Duan; Leng, Meng-Xin; Wang, Jian; Guo, Xue-Jun; Tan, Jia-Le; Cai, Xiao-Ting; Lin, Yan; Pan, Xinghua; Wu, De-Hua; Bai, Xue; Dong, Zhong-Yi Share Save 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
